22 March 2023

Last updated: Wednesday 22 March 2023

Policy & Regulation

After three years of Covid, risks to health remain

Novel oncology drugs approved in a year of change

Regulatory framework for real-world data progresses

Pharma should target fungal diseases, says WHO

Global regulators approve new cancer therapies

Europe creates network for data

Meeting the challenges of real-world data access

The quest for big data

EU revamps regulation of clinical trials

Oncology Review: A positive trajectory for approvals